BASINGSTOKE, United Kingdom, March 25, 2002 (PRIMEZONE) -- Shire Pharmaceuticals Group plc (LSE:SHP) (Nasdaq:SHPGY) (TSE:SHQ) will release historical financial data, in U.S. GAAP format, for each of the four quarters up to December 31, 2001 on Tuesday, March 26, 2002.
This statement will be published to provide the investment community with a complete historic quarterly analysis of the 2001 unaudited combined income statements, showing the impact of the pooling of interests accounting for the merger with BioChem Pharma, which completed on May 11, 2001.
Angus Russell, Shire Group Finance Director, will host a conference call to discuss the historical data, on Tuesday, March 26, 2002 at 3 p.m. GMT (10 a.m. EST). This call will not refer to current trading, current year results or future forecasts.
Calling Details:
United Kingdom: 44 (0) 207 984 7563
U.S. & Canada: 719-457-2617 or 1-800-231-9012
Passcode: 706223 or 'Shire'
Webcast:
The call will also be available live over the Internet via audio Webcast, accessible through www.shire.com in the investor relations section.
Replay:
All regions: 719-457-0820
Passcode: 706223
Webcast Replay: www.shire.com, in the investor relations section
The telephone replay will be available until midnight on Tuesday, April 9, 2002. The Webcast replay will be available until Thursday, April 25, 2002.
Notes to editors
Shire Pharmaceuticals Group plc
Shire Pharmaceuticals Group plc (Shire) is a rapidly growing international specialty pharmaceutical company with a strategic focus on three therapeutic areas -- central nervous system disorders (CNS), oncology and anti-infectives. Shire also has two platform technologies: advanced drug delivery and Biologics. Shire's core strategy is based on research and development combined with in-licensing and a focus on eight key pharmaceutical markets.
More details on Shire are available on the Shire Website at www.shire.com
THE "SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. The statements in this press release that are not historical facts are forward-looking statements that involve risks and uncertainties, including but not limited to, risks associated with the inherent uncertainty of pharmaceutical research, product development and commercialization, the impact of competitive products, patents, and other risks and uncertainties, including those detailed from time to time in periodic reports, including the Annual Report filed on Form 10K by Shire with the Securities and Exchange Commission.